Brief: Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila
08/02/2026 22:47
Feb 9 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: ALGORAE SIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILA SIGNS LICENSE AND SUPPLY AGREEMENT WITH CADILA AGREEMENT TO LAUNCH 2 GENERIC MEDICINES FOR CARDIOVASCULAR & METABOLIC DISORDERS IN AUSTRALIA & NEW ZEALAND Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative